학술논문
Interview: Following a standard of care for Huntington'a[euro][TM]s disease
Document Type
Interview
Author
Source
Neurodegenerative Disease Management. April 2012, Vol. 2 Issue 2, p159, 5 p.
Subject
Language
English
ISSN
1758-2024
Abstract
Author(s): G Bernhard Landwehrmeyer [sup.1] Q Can you summarize why the European Huntington'âs Disease Network was established and what you aim to provide to those involved in Huntington'âs disease research [...]
Georg Bernhard Landwehrmeyer is currently Professor of Neurology 'Clinical Neurobiology'â at the University Hospital of Ulm (Germany) where he is also Chair of the Executive Committee of the European Huntington'âs Disease Network. In 2011, he was predominately in New York, USA on sabbatical and is now currently a medical advisor to the CHDI Foundation. Landwehrmeyer received his Masters and PhD degrees at the Albert-Ludwigs University (Freiburg, Germany). He has also studied at the Royal Victoria Hospital, Queen'âs University (Belfast, UK), Kantonsspital (Basel, Switzerland) and MGH and Harvard Medical School, Boston. From 1995 to 1999, he was a staff member at the Albert-Ludwigs University in Freiburg Medical in Residency School (Departments of Neurology and Psychiatry). In 1999, he received his Board Certification in Neurology and 1 year later, the Venia Legendi and full Professorship ('C3'â) in Neurology at the University of Ulm. He has shown his expertise, especially in the field of Huntington'âs disease, in numerous clinical trials and researches both nationally and internationally.
Georg Bernhard Landwehrmeyer is currently Professor of Neurology 'Clinical Neurobiology'â at the University Hospital of Ulm (Germany) where he is also Chair of the Executive Committee of the European Huntington'âs Disease Network. In 2011, he was predominately in New York, USA on sabbatical and is now currently a medical advisor to the CHDI Foundation. Landwehrmeyer received his Masters and PhD degrees at the Albert-Ludwigs University (Freiburg, Germany). He has also studied at the Royal Victoria Hospital, Queen'âs University (Belfast, UK), Kantonsspital (Basel, Switzerland) and MGH and Harvard Medical School, Boston. From 1995 to 1999, he was a staff member at the Albert-Ludwigs University in Freiburg Medical in Residency School (Departments of Neurology and Psychiatry). In 1999, he received his Board Certification in Neurology and 1 year later, the Venia Legendi and full Professorship ('C3'â) in Neurology at the University of Ulm. He has shown his expertise, especially in the field of Huntington'âs disease, in numerous clinical trials and researches both nationally and internationally.